Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule

R. H. Earhart, J. M. Koeller, H. L. Davis

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish (US)
    Number of pages1
    JournalProceedings of the American Association for Cancer Research
    VolumeVol. 22
    StatePublished - Jan 1 1981

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this